Emboline expects that its technology designed to reduce stroke risk during structural heart procedures will launch in the US and Europe later this year.

Emboline has secured $20 million for its embolic protection system, designed to minimize stroke risk associated with transcatheter aortic valve replacement procedures. The Santa Cruz, CA-based company ...

Emboline, Inc., a privately held medical technology company focused on reducing stroke and ischemic damage during structural heart ...

The $550 million tuck-in deal is slated to close between late April and the end of October, during the first half of Medtronic’s 2027 fiscal calendar. The medtech giant described Scientia’s catalog as ...

Among patients with atrial fibrillation, those with a recent stroke are at significantly higher risk of recurrence than those without. Catheter ablation is expected to reduce the risk of ...

A new study finds that a significant portion of older adults with mild cognitive impairment or dementia develop new ...

Three-year outcomes from the PERFORMANCE II trial studying the Neuroguard Integrated Embolic Protection (IEP) 3-in-1 Carotid Sten ...

With the removal of FDA warning labels, hormone therapy to treat symptoms of menopause has grown in popularity.

Background Endovascular therapy (EVT) is standard treatment for large vessel occlusion in patients with a National Institutes ...

Add Yahoo as a preferred source to see more of our stories on Google. Veozah, also known as fezolinetant, blocks the nerve pathways in the brain that trigger hot flushes - Astellas /Astellas A daily ...

Medtronic today announced its entry into a definitive agreement to acquire Scientia Vascular, a company with critical, innovative technology across the neurovascular portfolio. The acquisition is ...

At Las Siete Regiones de Oaxaca in Pico Union, owner Lidia Young hears from customers that gas prices are playing a major factor in whether they can eat a ...